bioAffinity Technologies Inc. Common Stock. Replay the stock market charts of BIAF day by day, back to 2003. Open long and short positions without spending any money. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
